Scintigraphic evidence of effect of infliximab on disease activity in ankylosing spondylitis [6]

Rheumatology

Volumn 41, Issue 1, 2002, Pages 114-116

  Hadi, A ^a   Hickling, P ^a   Brown, M ^a   Al Nahhas, A ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID DERIVATIVE; INFLIXIMAB; MEDRONATE TECHNETIUM TC 99M; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE MARKER; DRUG EFFECT; DRUG INFUSION; HUMAN; INFLAMMATORY DISEASE; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL;

EID: 0036114854     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/41.1.114     Document Type: Letter

References (7)

1. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestation of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study
2. Dramatic response after an intravenous loading dose of azathioprine in one case of severe and refractory ankylosing spondylitis
3. Successful treatment of active ankylosing spondylitis with anti-tumour necrosis factor alpha monoclonal antibody infliximab
4. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: An open pilot study
5. 99mTc-MIBI scintigraphy in musculoskeletal tumors
6. Anti-TNFalpha: A new dimension in the pharmacotherapy of the spondyloarthropathies?
7. The arthritides